Sign Up to like & get
recommendations!
1
Published in 2021 at "Journal of Cardiovascular Pharmacology and Therapeutics"
DOI: 10.1177/10742484211034253
Abstract: Although decreased protein kinase G (PKG) activity was proposed as potential therapeutic target in heart failure with preserved ejection fraction (HFpEF), randomized clinical trials (RCTs) with type-5 phosphodiesterase inhibitors (PDE5i) showed neutral results. Whether specific…
read more here.
Keywords:
ejection fraction;
sildenafil therapy;
chronic sildenafil;
preserved ejection ... See more keywords